MedPath

Effect of Nano curcumin on the severity of diabetic sensorimotor polyneuropathy

Phase 3
Recruiting
Conditions
E11.43
Diadetic polyneuropathy.
Type 2 diabetes mellitus with diabetic autonomic (poly)neuropathy
Registration Number
IRCT20140413017254N5
Lead Sponsor
Tehran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
80
Inclusion Criteria

Age between 30 to 60 years old
desiration to participate in the study
Body mass index between25 - 39.9
Non-insulin diabetic patients type 2
Detection of mild sensorimotor polyneuropathy by using the Toronto questionnaire (score 6-8)

Exclusion Criteria

Follow a special diet during last month
Sensitivity to curcumin
Pregnancy and lactation
Eat any nutritional supplement, vitamin and mineral supplement last month
History of gastrointestinal ulcer and bile duct
There are neuropathies other than the sensory-motor polyneuropathy diabetic diagnosed by a neurologist
Take gabapentin and any medication
Diseases diagnosed, such as cancer, liver, kidney, autoimmune diseases, inflammatory, thyroid and nervous and cardiovascular diseases, and drug use associated with these diseases

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The severity of neuropathy in the Toronto questionnaire. Timepoint: Before the intervention, After intevention. Method of measurement: Toronto questionnaire.
Secondary Outcome Measures
NameTimeMethod
Fasting Blood Sugar. Timepoint: Before the intervention, After the intervention. Method of measurement: KIT.;Blood sugar 2 hour after meal. Timepoint: Before the intervention, After the intervention. Method of measurement: KIT.;HBA1C. Timepoint: Before the intervention, After the intervention. Method of measurement: KIT.
© Copyright 2025. All Rights Reserved by MedPath